AI
ALT icon

Atria Investments’s Altimmune ALT Stock Holding History

Atria Investments’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,285
Closed -$61.4K – 1984
2025
Q1 		$61.4K Buy
+12,285
New +$77.8K ﹤0.01% 1881
2024
Q3 		– Sell
-13,060
Closed -$86.8K – 1900
2024
Q2 		$86.8K Buy
+13,060
New +$96.4K ﹤0.01% 1875

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Atria Investments's ALT Position: Q2 2025 in Review

Atria Investments sold out of Altimmune (ALT) in Q2 2025, closing a stake of 12,285 shares — an estimated $61.4K sold.

Atria Investments first reported a position in ALT in Q2 2024 and held it in 2 quarters. The position peaked at $86.8K in Q2 2024. 180 funds tracked by Wall St. Rank hold ALT as of Q2 2025.

  • Atria Investments reported no remaining Altimmune position as of Q2 2025 after selling out during the quarter.
  • Atria Investments sold 12,285 Altimmune shares in Q2 2025, an estimated $61.4K.
  • Atria Investments first reported a position in Altimmune in Q2 2024 and held it in 2 quarters.
  • Atria Investments's Altimmune position peaked at $86.8K in Q2 2024.
  • 180 funds tracked by Wall St. Rank held Altimmune as of Q2 2025.

Based on Atria Investments's 13F filing for Q2 2025, filed 4 Aug 2025.